AtriCure, Inc. (ATRC) Reports Q4 Loss of $0.13

AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development